Avai Bio, Inc. (AVAI): Insider Trading, Congress Trades & Research | Tormere

AVAI

$0.09-5.10%visit website

AVAI BIO, INC.

Market Cap

$15M

Live price × SEC shares (Aug 13, 2026)

Sector

Information Technology

Industry

Technology

Beta (raw)

0.39

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q2 FY2026 Sep 30, 2025	Q3 FY2026 Dec 31, 2025	Q4 FY2026 Mar 31, 2026	Q1 FY2027 Jun 30, 2026	TTM Jun 30, 2026
Research & development	23.8	0.0	(8.8)
Total operating expenses	395	510	88	420	1,412
Operating income	(453)	(554)	(255)	(552)	(1,814)
Net income	(453)	(554)	(1,230)	(552)	(2,789)
EPS (basic) ($)	0.00	0.00		0.00	(0.01)
Weighted avg. shares (basic)	137,625	138,029		153,917

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 29 more quarters, back to Q1 FY2019, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Avaí Bio, Inc. (AVAI) stock price, news, quote and history

Yahoo Finance UK · 2026-10-29

Stocks in play: Avai Bio Inc

Yahoo! Finance Canada · 2026-10-28

Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery

Yahoo · 2026-10-28

Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program

Yahoo · 2026-10-07

Avaí Bio, JV Partner Austrianova Announce First Joint Steering Committee Meeting For Partnership With Ospedale San Raffaele Over Discussion On Initial Research Program To Mull Encapsulated Beta-Cell Replacement Approach For Insulin-Dependent Diabetes

Benzinga · 2026-10-07

Researchers will test whether insulin-making cells stay alive and work inside capsules.

Stock Titan · 2026-10-07

Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion

Yahoo Finance · 2026-09-30

Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference

Yahoo Finance · 2026-09-24

Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Yahoo Finance · 2026-08-12

A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up

Yahoo Finance · 2026-07-21

Avaí Bio, Austrianova Advance α-Klotho Cell Therapy Manufacturing Step

BioPharm International · 2026-05-21

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Yahoo Finance · 2026-05-20

Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference

Yahoo Finance · 2026-04-07

Avaí Bio (OTCPK:AVAI) - Stock Analysis

Simply Wall St · 2026-02-12

Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website

Yahoo Finance · 2026-02-11

Informational purposes only, not investment advice.